BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 19, 2015
View Archived Issues
ODYSSEY studies demonstrate greater LDL cholesterol reductions for alirocumab over placebo
Read More
New NIAID grant supports Inovio's collaborative HIV program
Read More
NantWorks and Sorrento Therapeutics establish new cancer immunotherapy collaboration
Read More
The Icahn School of Medicine at Mount Sinai presents Brd4 inhibitors
Read More
Cloud Pharmaceuticals and University of Florida collaborate on MTH1 inhibitors for cancer
Read More
Esperion's phase IIb study of ETC-1002 in hypercholesterolemia meets primary endpoint
Read More
Melphalan flufenamide receives U.S. orphan drug status for multiple myeloma
Read More
Aldeyra Therapeutics opens enrollment in Sjogren-Larsson syndrome trial
Read More
Pharmalink acquires osteoarthritis candidate from Synartro
Read More
Coherus finalizes CHS-1701 BLA-enabling program and begins pivotal PK study
Read More
Ezetimibe/simvastatin combination improves clinical efficacy in ACS patients
Read More
NovImmune's HLH trial of NI-0501 allows first-line treatment after protocol amendment
Read More
FDA approves Cholbam for rare bile acid synthesis disorders
Read More
Novogen reports on potential of Anisina to become new chemotherapy
Read More
Hsa-miRNA-181c shows potential as a new diagnostic marker for ACLF
Read More
Astellas submits supplemental NDA for Kiklin in Japan
Read More
Hanmi Pharmaceutical launches phase II trial of HM-61713
Read More
Collagen-targeted nanoparticles containing Ac2-26 peptide provide insight into atherosclerosis
Read More
Emergent manufactures MVA EBOZ Ebola vaccine candidate under new agreements
Read More
Prexa Pharmaceuticals patents monoamine transporter ligands
Read More
Kyoto Pharmaceutical develops novel aromatic compounds
Read More
French researchers report development of MMP inhibitors
Read More
Chinese researchers report mTOR and PI3Kalpha inhibitors
Read More
FDA extends Kalydeco approval to younger children with cystic fibrosis
Read More
AstraZeneca and Daiichi Sankyo sign U.S. co-commercialization agreement for Movantik
Read More
Case report of emergency postexposure vaccination with VSVdeltaG-ZEBOV
Read More
Allena reports phase IIa data on ALLN-177 for the treatment of hyperoxaluria
Read More